work in the bioincubator
RESEARCH FOUNDATION
TLS supports research activities in the Life Sciences and orphan diseases
work in the bioincubator
scientific publications since 2009
collaborations, agreements and licenses since 2007
active patents in 2017
of financing attracted by companies and research groups since 2007
of turnover by the incubated and affiliated companies and by the research groups in 2017
of income from TLS incubation activities and services
Toscana Life Sciences is a non-profit organization active throughout the region in supporting research activities and promoting the creation of innovative companies in the Life Sciences field. Founded at the instigation of Tuscany’s principal university, clinical, industrial and financial institutions, the Foundation is based in Siena, in the historical “Torre Fiorentina” area, where Achille Sclavo founded the eponymous Istituto Sieroterapico e Vaccinogeno Toscano in 1904, and where important multinational vaccine companies now strategically choose to locate their primary research and development activities. An environment of excellence that is part of a regional panorama in which the Life Sciences play a strategic role.
TLS supports research activities in the Life Sciences and orphan diseases
An incubator that is unique on the national panorama for its facilitation of the business startup process in the Life Sciences sector
Responsible for implementing research valorization activities for the Tuscany Region through the UVaR office
Coordinator and manager of the activities of the Tuscany Life Sciences Cluster
The know-how and experience of TLS in support of an ambitious project of the Tuscany Region
TLS represents the Tuscany Region in the national Life Sciences cluster ALISEI
TLS takes care of the administrative and organisational aspects of the training courses in the field of the industrial biotechnologies and medical devices.
We help Life Sciences start-ups and companies to structure and ramp up their business project, offering support for business development, from writing a business plan to the search for investors. read more
The incubated companies have access to a package of general and consulting services for routine management and commercial development needs. read more
We help you evaluate the assets of your research project, protect them and valorize their results, providing advice regarding intellectual property and technology transfer. read more
TLS makes technological platforms and equipment for research available to companies, start-ups and external groups. read more
The bioincubator is the natural habitat for the birth and development of new companies (start-ups and spin-offs) in the Life Sciences sector. A "home" where research groups and companies that are already active can also find spaces, technological facilities and services to grow and compete in the Life Sciences market. A dynamic environment with over 3000 square meters of laboratories in which to capitalize on ideas and construct valuable relationships.
Joining the bioincubator is simple. Discover how we can help you give birth to your company or develop your research activities within our spaces. We operate in the following sectors: biotech, pharma, medical devices, nutraceuticals, cosmeceuticals and ICT applied to heathacare. You can apply for incubation or choose the TLS affiliation path to use our services.
TLS is one of the beneficiaries of an Advanced Grant supported by the European Research Council to build a novel platform for the development of vaccines against infectious diseases and cancer.
The project, leaded by the scientist Rino Rappuoli, a pioneer in the vaccines field, is realised in cooperation with Toscana Life Sciences Foundation as “host institution” which make available laboratories, technology platforms and expertise inside an innovative and stimulating environment
AI4DIAg focuses on three technology areas (Image Processing, Medical Signal Analytics and Genomics) to develop and increase SME’s skills in the use and integration of Artificial Intelligence and Machine Learning algorithms in their solutions both from a technological and regulatory point of view.
The project has the ambitious aim to conceptually allow the molecular prediction of diabetes type 2 and the response or resistance to molecular targeting interventions through the development of an innovative LOC (lab on chip) able to reveal important epigenotypes and rare genetic variations.
Toscana Life Sciences will coordinate the project in partnership with excellent actors from Germany, Spain, Polland and with the Fondazione Regionale per la Ricerca Biomedica (Lombardy Region), in order to elaborate guidelines supporting future research and innovation programmes concerning Personalised Medicine.